Skip to content

Quality of Life Study About the Role of Turbinectomy in Rhinoseptoplasty

The Role of Turbinectomy in Rhinoseptoplasty: a Randomized Clinical Trial With Evaluation of Quality of Life

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02231216
Acronym
WHOQOL-BREF
Enrollment
50
Registered
2014-09-04
Start date
2014-03-31
Completion date
2016-07-31
Last updated
2019-01-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Deviated Nasal Septum, Nasal Septal Defect, Nasal Septum, Irregular

Keywords

rhinoseptoplasty

Brief summary

Research Question: Performing partial turbinectomy associated with rhinoseptoplasty is responsible for an increase in quality of life related to nasal obstruction when compared to no intervention in rhinoseptoplasty inferior turbinate? * Population: patients eligible for functional rhinoseptoplasty and / or aesthetic * Intervention: surgery, turbinectomy of inferior turbinates * Comparison: the absence of intervention in inferior turbinates * Primary endpoint: Quality of life related to nasal obstruction

Interventions

PROCEDURERhinoseptoplasty

Rhinoseptoplasty without turbinectomy procedure

After medial dislocation of the inferior turbinate, proceed partial resection of the inferior turbinate in all its inferior extension in range. Possible bleeding is cauterized.

PROCEDUREEndoscopic partial turbinectomy

Endoscopy to medial dislocation of the inferior turbinate with instrument

Sponsors

Hospital de Clinicas de Porto Alegre
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
6 Months to 90 Years
Healthy volunteers
No

Inclusion criteria

* Eligible patients to rhinoseptoplasty * Patients who agreed to participate

Exclusion criteria

* Presence of symptoms of nasal obstruction in the absence of septal deviation, poor support of the nasal tip or clamping of the nasal valve; * Presence of hypertrophic and obstructive inferior turbinates; * Presence of sinonasal tumors; * Patients undergoing treatment of other concomitant rhinoplasty entities such as inflammatory sinus pathology, adenoid hypertrophy, septal perforation, otoplasty and blepharoplasty.

Design outcomes

Primary

MeasureTime frameDescription
Quality of life related to nasal obstruction3 monthsQuality of life will be evaluated by the WHOQOL-BREF instrument, that comprises 26 items, which measure the following broad domains: physical health, psychological health, social relationships, and environment.

Secondary

MeasureTime frameDescription
Nasal Rhinorrhea3 MONTHSAt 90 posoperative day patients were asked if they had nasal rhinorrhea for more than one hour a day on most days, or not.
Nasal Pruritis3 MONTHSAt 90 posoperative day patients were asked if they had nasal pruritis for more than one hour a day on most days, or not.
Nasal sneezing3 MONTHSAt 90 posoperative day patients were asked if they had nasal sneezing for more than one hour a day on most days, or not.
Topical Nasal Corticosteroids3 MONTHSAt 90 posoperative day patients were asked if they were using topic nasal corticosteroids or not
Oral antihistamine3 monthsAt 90 posoperative day patients were asked if they had used oral antihistamine in the past 30 days or not
Allergic Conjunctivitis3 monthsAt 90 posoperative day patients were asked if they had allergic conjunctivitis for more than one hour a day on most days, or not.

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 14, 2026